Agios Pharmaceuticals, based in Cambridge, MA, leads in applying cellular metabolism research to transform treatments for rare diseases. Committed to improving patient lives through innovative approaches, Agios leverages its expertise in this specialized biomedical field to address unmet medical needs. The company maintains a focused presence with a dedicated professional following, underscoring its role in rare disease innovation.

‌